# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-22-016537
Filing Date
2022-04-29
Accepted
2022-04-28 19:08:01
Documents
7
Period of Report
2022-06-16

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | fgen-def14a_20220616.htm | DEF 14A | 2746973
2 | GRAPHIC | gxztqgadd1nq000002.jpg | GRAPHIC | 3738
3 | GRAPHIC | gxztqgadd1nq000003.jpg | GRAPHIC | 83600
4 | GRAPHIC | gxztqgadd1nq000006.jpg | GRAPHIC | 413240
5 | GRAPHIC | gxztqgadd1nq000005.jpg | GRAPHIC | 487798
6 | GRAPHIC | gxztqgadd1nq000001.jpg | GRAPHIC | 35334
7 | GRAPHIC | gxztqgadd1nq000004.jpg | GRAPHIC | 3641
| Complete submission text file | 0001564590-22-016537.txt |  | 4159682

Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36740 | Film No.: 22869070
SIC: 2834 Pharmaceutical Preparations